Arbutus Biopharma (ABUS) PT Lowered to $7 at JMP Securities

March 5, 2021 3:35 AM EST
Get Alerts ABUS Hot Sheet
Price: $3.07 -4.06%

Rating Summary:
    6 Buy, 3 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE
JMP Securities analyst Liisa Bayko lowered the price target on Arbutus Biopharma (NASDAQ: ABUS) to $7.00 (from $8.00) while maintaining a Market Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change